Abstract

The integration of artificial intelligence (AI) into drug discovery has revolutionized the pharmaceutical industry, offering unprecedented opportunities to accelerate the development of new therapies. This article explores the transformative impact of AI-powered drug discovery, detailing the methodologies, technologies, and applications that are reshaping the field. We discuss the role of machine learning, deep learning, and other AI techniques in target identification, drug design, and clinical trials. The article also examines the challenges and ethical considerations associated with AI in drug discovery, providing a comprehensive overview of the current state and future prospects of this rapidly evolving domain.